Want to join the conversation?
For FY16, $JWN expects net sales to increase in the range of 2.5-4.5%, retail EBIT to decrease in the range of 10-15% and credit EBIT to approximate $80MM. Diluted EPS, excluding the impact of any future share repurchases, is expected to range between $2.60-2.75 for FY16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?